Recall: Dabigatran
Apr. 2023Pharmacy Updates
Ascend Laboratories LLC has recalled 10 lots of Dabigatran capsules due to the presence of a nitrosamine, N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level. Dabigatran is a drug used as an oral anticoagulant to lower the risk of stroke and blood clots. Read more about the Dabigatran recall.
Recent Announcements
Certified Community Health Worker (CCHW) Provider Billing Notification
UPMC for You will now reimburse for up to three certified community health worker (CCHW) visits per member per calendar year for Medicaid recipients, per the Pennsylvania Department of Human Services (PA DHS).Apr. 2026Important Notices
CME Webinar: First Annual Dr. Jim Withers Lecture
Please join us for the First Annual Dr. Jim Withers Lecture, featuring Dr. Jim Withers, a global leader in compassionate, justice-centered careApr. 2026Education/Webinars
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Apr. 2026Important Notices
